Urological Diseases: Updates and Challenges on Personalized Diagnosis, Treatment, and Management

Dear Colleagues,

Urology stands at the cutting edge of surgical innovation. Over recent decades, the introduction of new technologies and surgical approaches has revolutionized the management of numerous urological disorders, significantly enhancing patient outcomes. Minimally invasive techniques, in particular, have driven substantial advancements in oncological and functional results, reducing morbidity and improving patients' quality of life. Cutting-edge advancements in the diagnosis and treatment of various urological diseases have led to the development of advanced imaging techniques, molecular diagnostics, and refined diagnostic strategies that are currently shaping contemporary urological practice.

In the last decades, daily urology practice has been faced the dynamic evolution of urological surgeries. Urologic surgical interventions have progressed from established open procedures to the transformative adoption of minimally invasive techniques, such as advanced laparoscopy, endoscopy, and the widespread integration of robotic platforms. These advancements have demonstrably improved patient outcomes, reduced morbidity, and enhanced quality of life, underscoring a field propelled by continuous technological innovation and clinical necessity.

Furthermore, other surgical fields have evolved, reducing the disease burden of major common diseases, such as obesity, that affect the majority of urological problems. A main question remains as to how surgical advancements and techniques have developed in other organs and specialties, and how they are adapted and applied to treat urological problems. Advancements in methodologies, technologies, or principles from non-urological surgeries have found effective application in addressing complex urological challenges, thereby fostering new opportunities for interdisciplinary collaboration and innovative patient care.

This Special Issue aims to provide compelling scientific evidence on the current state and future directions of urological care, focusing on both the diagnosis and treatment of urological diseases, and welcoming original research and insightful reviews that contribute to this vital discussion.

Prof. Dr. Michael Chrisofos
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.